Company Filing History:
4 out of 52 
1 out of 1 
1 out of 1 Years Active: 2002-2014
Title: Innovations and Contributions of Isabella Caniggia
Introduction
Isabella Caniggia is a prominent inventor based in Toronto, Canada. She has made significant contributions to the field of medical research, particularly in the area of diagnosing and treating conditions related to hypoxia. With a total of six patents to her name, her work has had a substantial impact on healthcare.
Latest Patents
Isabella's latest patents include groundbreaking inventions such as antibodies against human HIF-1α. This invention relates to reagents and methods for detecting, diagnosing, and screening for conditions associated with hydroxylated hypoxia-inducible factor 1-α (HIF-1α). Additionally, she has developed a method for diagnosing an increased risk of preeclampsia by measuring the level of HIF-1α. These methods involve measuring levels of TGF-β, receptors of cytokines of the TGF-β family, or HIF-1α, providing valuable tools for patient diagnosis and treatment.
Career Highlights
Throughout her career, Isabella has worked with esteemed institutions, including Mount Sinai Hospital Corporation. Her research has been pivotal in advancing our understanding of hypoxia-related conditions and their implications for patient care.
Collaborations
Isabella has collaborated with notable professionals in her field, including Martin Post and Stephen Lye. These partnerships have enhanced her research and contributed to the development of innovative medical solutions.
Conclusion
Isabella Caniggia's contributions to medical research and her innovative patents underscore her role as a leading inventor in her field. Her work continues to influence the diagnosis and treatment of critical health conditions, making a lasting impact on healthcare.